Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)
Stem Cells Transl Med. 2024 Oct 14:szae071. doi: 10.1093/stcltm/szae071. Online ahead of print. ABSTRACT Hypoxic-ischemic encephalopathy (HIE), associated with high mortality and neurological sequelae, lacks …